Pfizer’s Post

View organization page for Pfizer

6,682,755 followers

Technology meets purpose in this powerful conversation on AI’s role in patient care with Lidia Fonseca and Dr. Sue Desmond-Hellmann. #ThePowerofKnowing.

In the latest episode of #ThePowerofKnowing series, I had the privilege of speaking with Dr. Sue Desmond-Hellmann about how AI is transforming health outcomes by enhancing disease identification, enabling personalized treatment, and accelerating drug development. Sue’s experience as a renowned oncologist, scientist, and former CEO of the Gates Foundation brings rich insights to our conversation. A few key learnings: AI is an accelerant to help us drive faster, smarter breakthroughs; responsibility and ethics play a key role in successful outcomes; and I loved Sue’s advice about “learning to learn” to cope with a rapidly evolving world. Sue also spoke about how AI can help us understand why certain cancers, like colon cancer, are appearing in younger patients, speeding up epidemiological work and diagnosis, and creating the possibility to develop treatments with improved targeting. These considerations are essential to Pfizer’s work in oncology, consumer health, and cross-industry partnerships, which we also discussed in this conversation.  🎥 Watch this episode of #ThePowerofKnowing to join the conversation: https://lnkd.in/eMErKR7v.

Really interesting to see the level of impact AI is having in healthcare right now. I’m learning how it’s shaping precision medicine and speeding up drug development—it’s amazing to see the potential it has. I also really appreciate Dr. Sue’s insights on responsibility and continuous learning

Like
Reply

This is a technological advancement and an industry iteration.

Like
Reply

Inspiring to see AI driving meaningful change in patient care.

Like
Reply

Thoughtful post, thanks

Like
Reply

AI will be playing crucial role in patient care in near future!

Like
Reply
See more comments

To view or add a comment, sign in

Explore content categories